ADVANCED WOUND MANAGEMENT

SECURA^◊ Skin Care Range

Formulated to help protect, cleanse and moisturize the skin as part of an effective skincare regimen for indications such as pressure injuries, incontinence-associated dermatitis (IAD) or moisture-associated skin damage (MASD)¹

Product Range

Medical Education

No results

Disclaimers

Precautions

For external use only. If irritation occurs, consult a physician.

Warnings

For external use only. Avoid contact with eyes. Not to be applied over deep or puncture wounds, infections or lacerations. If condition worsens or does not improve within 7 days, consult a doctor. Keep this and all drugs out of the reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Disclaimer

For detailed product information, including indications for use, ingredients, directions, contraindications, precautions, warnings and/or important safety information, please consult each product’s package labelling, Instructions for Use (IFU) and/or drug facts prior to use.

Recall and Complaints

Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to complaints@smith-nephew.com.

Terms & Conditions and Warranties

Citations

1. European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. Emily Haesler (Ed.). EPUAP/NPIAP/PPPIA: 2019.

2. Smith+Nephew 2020. Internal report. PSS415.

3. Monograph Title 21 CFR Part 347 - Skin Protectant Drug Products for Over the Counter Human Use Final Monograph 06/2003.

4. Fiers, S.A. OWM, vol 43, no 3, April 1996, 32-42.

5. Scheps M.H. Home Health Care Consultant, vol 3l NO 1, Jan-Feb 1996, 37-39.

6. Smith+Nephew 2019. Internal report. RD/19/026/v2.

7. Hilltop Research 2007. Internal report. 07-128386-111.

8. Nursing Care Moisturizing Cream Formulation (F-50). 2009.

9. Evaluation of Cumulative Irritation Potential in Humans (21-day), Report # 94-2404-72A, Hill Top Research.

10. Monograph Title 21 CFR Part 347 - Skin Protectant Drug Products for Over the Counter Human Use final Monograph 06/2003.

11. Brett, D. The justification of Secure Anti-Fungal Extra Thick Cream formulated to not wash away even in severe cases of diarrhea and soothing and gentle to the skin. 2017.

12. Title 21 CFR, Part 333, SubpartC - Topical Antifungal Drug Products.

13. Smith+Nephew 2020. The justification of pH buffered claim for the total body foam cleanser (TBFCI). Internal report.

14. Microbiotest report: Chlorhexidine Gluconate compatibility Evaluation of Skin Treatment Products. 2020.